Q1 2022 Astellas Pharma Inc Earnings Call Transcript
Hello, everyone. I'm CSO and CFO at Astellas Pharma Inc. I'm Naoki Okamura. Thank you very much for joining our conference call on our financial results for the first quarter of fiscal year 2021.
As usual, I will give you an overview of financial results and explain our initiatives for sustainable growth. It maybe unusual to say what is not in the script at the beginning. But first of all, we'd like to apologize for the first quarter results, which are not as good as we expected.
So looking at the (inaudible) of the stock market, it reflects the feelings of the investors. So we apologize to the shareholders as well. We are announcing our CSP plan, but we are not complacent. Maybe we were not so careful about what we are doing right now. And so we try to deliver the fiscal year 2021 results. So we'd like to do our best.
Let me move on. Page 2 is a cautionary statement regarding forward-looking information read by (inaudible). So I'd like to skip.
Page 3. Today
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
